期刊文献+

MMP-9蛋白和微血管密度在子宫内膜异位症中的表达及意义 被引量:2

The Expression of MMP-9 and Microvessel Density in Endometriosis and its Significance
下载PDF
导出
摘要 目的研究MMP-9和微血管密度(MVD)值在子宫内膜异位症(内异症)患者的异位内膜组织中的表达,探讨其与EMs发生发展的关系。方法用免疫组化方法检测45例患者异位子宫内膜组织和15例对照子宫内膜组织中MMP-9和微血管密度的表达。结果 (1)异位内膜细胞中MMP-9的表达明显高于在位内膜和对照内膜;(2)微血管密度值在异位内膜中的表达明显高于在位内膜和对照内膜;(3)MMP-9与微血管密度在异位内膜中的表达没有相关性(P>0.05),在对照内膜中的表达也无相关性(P>0.05)。结论 MMP-9、微血管密度在子宫内膜异位症的异位内膜表达增高,这些结果可能与异位内膜的侵袭有关。 Objective To study the expression of MMP - 9 and microvessel density (MVD) in ectopic endometrial tissue of the patients with endometfiosis (EMs) and to explore its relatianship with the occurrence and progress of EMs. Methods The expression of MMP -9 and MVD in ectopic endometfial tissue of 45 cases with EMs and of 15 normal as the control was detected by immunohistochemical study. Results The expression of MMP - 9 and the MVD were much higher in ectopic endometrial cells than those in the normal control; there ex- isted no correlation between the expression of MMP - 9 and that of MVD in ectopic endometHam (P 〉 0. 05 ) as well as in the control endo- metriam (P 〉 O. 05 ). Conclusions It may be related to the invasion of ectopic endometriam that the expression of MMP - 9 and MVD in- creases in ectopic endometriam of the patients with EMs.
作者 谢佳 李宗恒
出处 《西南军医》 2010年第5期825-827,共3页 Journal of Military Surgeon in Southwest China
关键词 子宫内膜异位症 MMP-9 微血管密度 免疫组织化学 endometriosis (EMs) MMP - 9 microvessel density immunohistochemistry
  • 相关文献

参考文献9

二级参考文献33

  • 1申洪.免疫组织化学染色定量方法研究(Ⅲ)[J].中国组织化学与细胞化学杂志,1995,4(1):89-92. 被引量:398
  • 2徐红,欧奇志,况燕,张玮,徐文生.动态检测子宫内膜异位症患者血清血管内皮生长因子的临床意义[J].实用妇产科杂志,2005,21(10):598-600. 被引量:1
  • 3郭海秀,陈向伟.VEGF在子宫内膜异位症中的表达[J].山西医科大学学报,2006,37(1):46-48. 被引量:4
  • 4Koks CAM,Groothuis PG,Slaats P,et al.Matrix metalloproteinases and their tissue inhibitors in antegradely shed menstruum and peritoneal fluid[J].Fertil Steril,2000,73:604-612.
  • 5Nap AW,Dunselman GA,de Goeij AF,et al.Inhibiting MMP activity prevents the development of endometriosis in the chicken chorioallantoic membrane model[J].Hum Reprod,2004,19:2180-2187.
  • 6Osteen KG,Bruner KL,Sharpe-Timms KL.Steroid and growth factors,regulation of matrix metalloproteinase expression and endometriosis[J].Sem Rep Endocr,1996,14:247-255.
  • 7Mizumoto H,Saito T,Ashihara K.Expression of matrix metalloproteinases in ovarian endometriomas:immunohistochemical study and enzyme immunoassay[J].Life Sci,2002,71:259-273.
  • 8Collette T,Bellehumeur C,Kats R,et al.Evidence for an increased release of proteolytic activity by the eutopic endometrial tissue in women with endometriosis and for involvement of matrix metalloproteinase-9[J].Hum Reprod,2004,19:1257-1264.
  • 9Sharpe-Timms KL,Zimmer RL,Jolliff WJ,et al.Gonadotropin-releasing hormone agonist (GnRH-a) therapy alters activity of plasminogen activators,matrix metalloproteinases,and their inhibitors in rat models for adhesion formation and endometriosis:potential GnRH-a-regulated mechanisms reducing adhesion formation[J].Fertil Steril,1998,69:916-923.
  • 10Cornillie FJ,Oosterlynck D,Lauweryns JM,et al.Deeply infiltrating pelvic endometriosis:Histology and clinical significance[J].Fertil Steril,1990,53:978-983.

共引文献549

同被引文献10

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部